GreenLight Biosciences Holdings Buy Hold or Sell Recommendation

GRNAWDelisted Stock  USD 0.02  0  25.00%   
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding GreenLight Biosciences Holdings is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell GreenLight Biosciences Holdings given historical horizon and risk tolerance towards GreenLight Biosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for GreenLight Biosciences Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note, we conduct extensive research on individual companies such as GreenLight and provide practical buy, sell, or hold advice based on investors' constraints. GreenLight Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Execute GreenLight Biosciences Buy or Sell Advice

The GreenLight recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GreenLight Biosciences Holdings. Macroaxis does not own or have any residual interests in GreenLight Biosciences Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GreenLight Biosciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell GreenLight BiosciencesBuy GreenLight Biosciences
Not Rated
For the selected time horizon GreenLight Biosciences Holdings has a Risk Adjusted Performance of 0.01, Jensen Alpha of (0.49), Total Risk Alpha of (2.83), Sortino Ratio of (0.01) and Treynor Ratio of 1.0E-4
We provide advice to complement the regular expert consensus on GreenLight Biosciences. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. Use GreenLight Biosciences ebitda, debt to equity, as well as the relationship between the Debt To Equity and retained earnings to ensure your buy or sell decision on GreenLight Biosciences is adequate. As GreenLight Biosciences appears to be a penny stock we also urge to confirm its book value per share numbers.

GreenLight Biosciences Trading Alerts and Improvement Suggestions

GreenLight Biosciences is not yet fully synchronised with the market data
GreenLight Biosciences has some characteristics of a very speculative penny stock
GreenLight Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 6.38 M. Net Loss for the year was (167.06 M) with profit before overhead, payroll, taxes, and interest of 0.
GreenLight Biosciences Holdings has accumulated about 34.75 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

GreenLight Biosciences Returns Distribution Density

The distribution of GreenLight Biosciences' historical returns is an attempt to chart the uncertainty of GreenLight Biosciences' future price movements. The chart of the probability distribution of GreenLight Biosciences daily returns describes the distribution of returns around its average expected value. We use GreenLight Biosciences Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GreenLight Biosciences returns is essential to provide solid investment advice for GreenLight Biosciences.
Mean Return
0.01
Value At Risk
-26.09
Potential Upside
32.45
Standard Deviation
17.96
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GreenLight Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

GreenLight Biosciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GreenLight . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About GreenLight Biosciences Buy or Sell Advice

When is the right time to buy or sell GreenLight Biosciences Holdings? Buying financial instruments such as GreenLight Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having GreenLight Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Cap ETFs Thematic Idea Now

Small Cap ETFs
Small Cap ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small Cap ETFs theme has 167 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Cap ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in GreenLight Stock

If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume